Wunderlich bumps PT on Symmetry Medical, sees 6% Implant and Cases growth

|About: Symmetry Medical Inc. (SMA)|By:, SA News Editor

A PT hike to $11 from $10 at Wunderlich Securities may be helping Symmetry Medical shares (SMA +2.8%) higher.

Analyst James Terwilliger, which has a Buy rating on the name, believes 2014 revenue growth will be driven by a 6% boost in the Implant and Cases product lines.

On the balance sheet side, Terwilliger postulates that "management will remain focused on reducing debt levels."